Home » Dilantin

Dilantin

Share Button

Dilantin Described

Dilantin is a prescription anticonvulsant drug which was originally developed as a treatment for individuals suffering from seizures and other seizure-related disorders. The active ingredient in Dilantin is phenytoin sodium, and the drug functions by slowing down impulses in the brain which are responsible for causing seizures. Dilantin was approved by the FDA in 1953 specifically to prevent grand mal and complex partial seizures associated with epilepsy, although the drug is also often prescribed for off-label purposes like anxiety control and mood stabilization, when physicians deem Dilantin treatment appropriate. Dilantin is also indicated for the prevention and treatment of seizures occurring during or following neurosurgery. Dilantin is currently manufactured by Pfizer, Inc. and can be found in 30mg and 100mg extended oral capsules.

Dilantin and Major Side Effects

Phenytoin (Dilantin) has been associated with an increased risk of life-threatening conditions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). SJS is a devastating skin condition in which cell death causes the epidermis to separate from the dermis, most often caused by hypersensitivity of the skin and mucous membranes to certain pharmaceutical medications. Individuals with SJS typically present with mild symptoms like fever, fatigue and sore throat, which quickly progress into a rash or blisters covering the body, and may even lead to the death and shedding of the top layer of skin in severe instances. Individuals with SJS often experience devastating and potentially fatal complications, including permanent skin damage, organ damage, renal failure, blindness, and respiratory failure. Some experts believe that TEN is a more advanced form of SJS, as the symptoms of the conditions are similar, but TEN is characterized by the loss of a larger percentage of the body’s epidermis. TEN is also most often caused by a severe reaction to certain pharmaceutical medications, resulting in the separation of the epidermis from the dermis all over the body.

Dilantin and Severe Birth Defects

The allegedly increased risk of major birth defects among infants exposed to Dilantin in utero is believed to be associated with the drug containing the ingredient phenytoin. Phenytoin is a known teratogen, which describes any drug with the ability to interrupt fetal development and cause fetal malformations. The teratogenicity of many drugs is believed to be due to the drugs’ potential to inhibit folic acid absorption, which can interfere with the formation of blood vessels and cause fetal malformations like neural tube birth defects. Some of the birth defects potentially associated with the use of phenytoin (Dilantin) include:

  • Cleft palate
  • Cleft lip
  • Growth retardation
  • Mental retardation
  • Heart defects
  • Fetal Hydantoin Syndrome
  • Neural tube birth defects

Dilantin Birth Defect Studies

According to a revealing 2001 study published by the New England Journal of Medicine, infants who are exposed to anticonvulsant drugs during pregnancy may have an increased risk of developing one or more major birth defects, compared to infants who are not exposed to these drugs in utero. Researchers involved in this study screened over 100,000 pregnant women at five Boston-area hospitals between 1986 and 1993 and divided the women into separate groups based upon anticonvulsant exposure. According to the report, 20.6% of infants exposed to one anticonvulsant drug during pregnancy were born with major birth defects, compared to 28% of infants exposed to two or more anticonvulsants in utero, and 8.5% of unexposed infants. Among the women who took only one anticonvulsant drug while pregnant, 87 took phenytoin (Dilantin), 58 took carbamazepine (Tegretol), and six took valproic acid (Depakote), among other drugs. The birth defects observed among infants exposed to one or more of these anticonvulsant medications included microcephaly (defect of the skull), limb defects, anal atresia (absent or misplaced opening to the anus), hypospadias (genital defect in males), heart defects, cleft lip, cleft palate, growth retardation, hypoplasia of the midface, hypoplasia of the fingers, and spina bifida. After reviewing these results, researchers concluded that anticonvulsant drugs are one of the most common causes of potential harm to a fetus in utero.

Dilantin Use and Pregnancy

The FDA has classified Dilantin as a pregnacy category D medication, which means there is positive human evidence of the drug’s potential to cause serious harm to a fetus when taken during pregnancy. The FDA has also advised physicians to avoid prescribing category D medications like Dilantin to pregnant women unless the possible benefits of the drug justify the potential risks to the fetus. If you are currently taking Dilantin and you are pregnat or planning to become pregnant, consult your healthcare provider as soon as possible. It may be dangerous to suddenly discontinue use of a prescription drug without medical consent, but with your doctor’s help, you may be able to find a safer way to treat your condition.

A Dilantin Attorney Can Help

Dilantin and other anticonvulsant medications may cause devastating side effects like SJS and TEN, as well as catastrophic birth defects for individuals exposed to the drug in utero. If you or a loved one has suffered from a birth defect which you believe to be associated with the use of Dilantin, contact a Dilantin attorney to discuss your legal options. You may have grounds to file a Dilantin lawsuit against Pfizer in order to seek financial compensation for your injuries, the medical expenses associated with injury treatment, and the pain and suffering endured by you and your family.

You are not responsible for serious injuries resulting from the use of a dangerous drug. Pharmaceutical companies should be held accountable for the safety of their medications and for any adverse side effects sustained by consumers of their products. Unfortunately, many drug manufacturing companies operate in their own best interest, disregarding the safety of millions of consumers. Defective drug litigation can be a complicated process, but with the help of an experienced Dilantin lawyer, victims of alleged Dilantin birth defects can protect their rights and collect the reimbursement they are entitled to.

Alimta Kidney Damage

Study Links Popular Mesothelioma Cancer Drug to Increased Risk of Kidney Damage Alimta, the drug commonly used to treat mesothelioma cancer, may put patients at risk for severe kidney damage. Researchers involved in a new study are warning that the popular mesothelioma drug Alimta may put patients at an increased risk for kidney damage, even otherwise healthy patients with no ...

Read More of - Alimta Kidney Damage

Pediatric Medication Errors

New Research Explores Ways to Limit Child Medication Errors Drug prescribing and administration errors among children lead to approximately 7,000 child deaths every year. The findings of two new studies outline the potential health risks children may face from pharmaceutical drug errors, and suggest new ways medical professionals may be able to help parents avoid dosing errors and the resulting ...

Read More of - Pediatric Medication Errors

“Hide No Harm” Bill Proposed

Proposed Bill Would Make it Illegal for Companies to Conceal Defects, Side Effects Corporate officials could face significant fines and jail time for knowingly withholding defective drug and product information from consumers, with this proposed bill. New legislation proposed in the U.S. Senate would make it illegal for drug and product manufacturing companies to knowingly withhold information about a dangerous ...

Read More of - “Hide No Harm” Bill Proposed

TRT Health Risks

Heart Problems Linked to Testosterone Therapy Result in Health Canada Warning Men undergoing TRT treatment for low testosterone may face an increased risk of heart attack, stroke and other heart problems. Health officials in Canada are warning consumers about the possible risk of serious heart problems associated with low T treatments like AndroGel and Testim. According to a safety update ...

Read More of - TRT Health Risks

Benicar Gastrointestinal Problems

Risk of Benicar Side Effects May More than Triple After First Year of Treatment The risk of patients suffering serious complications from Benicar may increase more than three-fold after one year of treatment, and nearly ten-fold after two years. According to the findings of an important new study, a patient’s risk of suffering Benicar complications like chronic diarrhea and sprue-like ...

Read More of - Benicar Gastrointestinal Problems

Tylenol Liver Failure

New Report Outlines Risks of Unintentional Acetaminophen Overdose Consumers are being warned by a new report about the risks of acetaminophen overdose and Tylenol liver injury resulting in liver failure. A new report issued by a group of medical professionals and consumer advocate groups warns consumers about the risk of acetaminophen and Tylenol overdose, highlighting the importance of increased education ...

Read More of - Tylenol Liver Failure

Xarelto Bleeding Risks

Reports Involving Xarelto Blood Thinner Complications on the Rise A growing number of reports involving bleeding side effects of Xarelto are being submitted to federal drug regulators. As more and more people are prescribed the controversial blood thinner drug Xarelto, the number of uncontrollable bleeding side effects reported in connection with the medication continue to increase. If you believe you ...

Read More of - Xarelto Bleeding Risks